Fig. 2: Figure Assessment of relationship between Prosigna® and RUO ROR scores. | npj Breast Cancer

Fig. 2: Figure Assessment of relationship between Prosigna® and RUO ROR scores.

From: Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

Fig. 2: Figure Assessment of relationship between Prosigna® and RUO ROR scores.

Comparison of commercial Prosigna® scores and RUO ROR scores (A) within the TransATAC validation set (n = 48) and (B) within the combined Spanish cohort (n = 143). Patients are represented in low-risk group with green, in intermediate-risk group with orange and high-risk group with red as stratified by the commercial test. RUO: research use only.

Back to article page